<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Role of echocardiography in atrial fibrillation
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Role of echocardiography in atrial fibrillation
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Role of echocardiography in atrial fibrillation
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Warren J Manning, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Bradley P Knight, MD, FACC
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Susan B Yeon, MD, JD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Feb 03, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Atrial fibrillation (AF) is the most common treated arrhythmia. Echocardiography plays a key role in evaluation and management of patients with AF.
        </p>
        <p>
         The topic will review the use of echocardiography in evaluating patients with AF. An overview of AF is presented separately. (See
         <a class="medical medical_review" href="/z/d/html/1022.html" rel="external">
          "Atrial fibrillation: Overview and management of new-onset atrial fibrillation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4190692820">
         <span class="h1">
          OBJECTIVES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The role of echocardiographic imaging among patients with AF can be divided into two main categories:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Assessment of cardiac chamber sizes and function, the atrial contribution to left ventricular filling, the pericardium, and valvular function. This information may be helpful in determining the conditions associated with AF, the risk for recurrent AF following cardioversion, and the hemodynamic benefit of maintaining sinus rhythm. This information is generally obtained from transthoracic echocardiography (TTE), with moderately invasive transesophageal echocardiography (TEE) generally reserved for assessment of the left atrial appendage for thrombus prior to cardioversion. (See
         <a class="medical medical_review" href="/z/d/html/1004.html" rel="external">
          "Epidemiology, risk factors, and prevention of atrial fibrillation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1035.html" rel="external">
          "Antiarrhythmic drugs to maintain sinus rhythm in patients with atrial fibrillation: Recommendations"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Identification of patients at increased risk for thromboembolic complications of AF before cardioversion and in patients with chronic AF. (See
         <a class="medical medical_review" href="/z/d/html/906.html" rel="external">
          "Prevention of embolization prior to and after restoration of sinus rhythm in atrial fibrillation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/128998.html" rel="external">
          "Atrial fibrillation in adults: Selection of candidates for anticoagulation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4053092277">
         <span class="h1">
          INDICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nearly all patients presenting with their first episode of AF will benefit from transthoracic (surface) echocardiographic (TTE) evaluation of left atrial size, left ventricular cavity size and regional/global systolic function, and mitral valve morphology and function. Examination of prior TTE data (if available) may allow for assessment of the atrial contribution to left ventricular filling (transmitral Doppler peak A wave velocity) when the patient is in sinus rhythm so as to have an assessment of the atrial contribution to ventricular filling. (See
         <a class="local">
          'Transthoracic echocardiography'
         </a>
         below.)
        </p>
        <p>
         A more selected subgroup may benefit from the additional information obtained from transesophageal echocardiographic (TEE) evaluation for left atrial thrombi to allow for early cardioversion if no thrombi are identified. (See
         <a class="local">
          'Transesophageal echocardiography'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/906.html" rel="external">
          "Prevention of embolization prior to and after restoration of sinus rhythm in atrial fibrillation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          TRANSTHORACIC ECHOCARDIOGRAPHY
         </span>
         <span class="headingEndMark">
          —
         </span>
         TTE provides detailed information about cardiac anatomy and function. In comparison to TEE, TTE is less useful for the detection of atrial thrombus, especially thrombus in the right atrial appendage or left atrial appendage (LAA), which is better detected by TEE. (See
         <a class="local">
          'Left atrial thrombi'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Left atrial size
         </span>
         <span class="headingEndMark">
          —
         </span>
         TTE is particularly helpful in assessing the size of the body of the left atrium. The normal left atrial dimension in adults is less than 4.0 cm (or less than 2.0 cm/m
         <sup>
          2
         </sup>
         body surface area) or biplane derived left atrial volume index of less than 34 mL/m
         <sup>
          2
         </sup>
         body surface area. Left atrial enlargement is common in AF, particularly in patients with mitral valve disease (both stenosis and regurgitation), left ventricular cavity dilation, annular calcification, or hypertension [
         <a href="#rid1">
          1
         </a>
         ]. In addition, sustained AF itself can lead to a further increase in left atrial size [
         <a href="#rid2">
          2
         </a>
         ], an effect that is reversible after cardioversion and maintenance of sinus rhythm [
         <a href="#rid3">
          3
         </a>
         ]. Pulsed Doppler studies have shown that the time to recovery of atrial mechanical function is directly related to the duration of AF (eg, within 24 hours in patients with AF for less than 2 weeks; up to a week for patients who have been in AF for two to six weeks; and up to a month for patients with sustained AF for more than six weeks) [
         <a href="#rid4">
          4
         </a>
         ]. However, the routine serial assessment of atrial mechanical function recovery is not recommended and TTE Doppler assessment of atrial recovery does not predict long term maintenance of sinus rhythm. (See
         <a class="medical medical_review" href="/z/d/html/5326.html" rel="external">
          "Echocardiographic evaluation of the atria and appendages"
         </a>
         .)
        </p>
        <p>
         Regardless of the mechanism, left atrial enlargement is important prognostically. It decreases the probability that long-term maintenance of sinus rhythm will be successful [
         <a href="#rid5">
          5-7
         </a>
         ]. Patients with chronic (more than one year) AF, rheumatic mitral valve disease, or severe left atrial enlargement (dimension greater than 6.0 cm or left atrial volume greater than 48 mL/m
         <sup>
          2
         </sup>
         ) are at greatest risk for recurrent AF [
         <a href="#rid7">
          7
         </a>
         ]. If, however, the duration of AF is brief, an attempt at cardioversion is reasonable for most patients regardless of absolute left atrial size. (See
         <a class="medical medical_review" href="/z/d/html/1025.html" rel="external">
          "Atrial fibrillation: Cardioversion"
         </a>
         .)
        </p>
        <p>
         Although TTE can provide anatomic imaging of the body of the left atrium, TEE is preferred when looking for left atrial thrombi and assessing LAA and right atrial appendage anatomy and function (abnormalities of which predispose to the thrombus formation), as these areas are not well seen on TTE. Few data are known regarding the impact of AF on atrial appendage anatomy, though sustained AF does lead to progressively more impaired LAA ejection velocity. (See
         <a class="local">
          'Transesophageal echocardiography'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Mitral valve function
         </span>
         <span class="headingEndMark">
          —
         </span>
         TTE is quite useful in the assessment of mitral valve anatomy and function, which can influence the risk of thrombus formation. As an example, occult mitral stenosis in the adult may initially present with AF, often in the setting of acute thromboembolism. In this setting, long-term oral anticoagulation is indicated even if cardioversion to sinus rhythm is successful and independent of CHA
         <sub>
          2
         </sub>
         DS
         <sub>
          2
         </sub>
         -VASc score (these clinical thromboembolism scores were derived from non-valvular AF populations). Long-term maintenance of sinus rhythm is unlikely unless the mitral stenosis (by surgery or percutaneous balloon mitral valvuloplasty) or severe mitral regurgitation (surgical repair or replacement) is corrected. (See
         <a class="medical medical_review" href="/z/d/html/8140.html" rel="external">
          "Surgical and investigational approaches to management of mitral stenosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8161.html" rel="external">
          "Percutaneous mitral balloon commissurotomy in adults"
         </a>
         .)
        </p>
        <p>
         Mitral regurgitation is commonly found among patients with AF. More than moderate mitral regurgitation appears to
         <strong>
          protect
         </strong>
         against clinical thromboembolism in chronic AF, presumably by minimized stasis in the left atrium and LAA [
         <a href="#rid8">
          8-11
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/981.html" rel="external">
          "Mechanisms of thrombogenesis in atrial fibrillation"
         </a>
         ). However, mitral regurgitation does not appear to protect from the formation of LAA thrombus as identified on TEE.
        </p>
        <p>
         As mentioned, examination of a prior TTE when the patient is in sinus rhythm (if available) will provide useful information on the relative atrial contribution to total left ventricular filling by examining the transmitral peak A wave velocity or peak E to peak A wave ratio. For those patients with a relatively high/large transmitral A wave, the contribution of left atrial systole to left ventricular filling is greater. Thus, these patients may derive greater hemodynamic benefit from rhythm control.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Left ventricular function
         </span>
         <span class="headingEndMark">
          —
         </span>
         All patients with newly discovered AF should have a TTE to assess for LV size and function and other structural cardiac conditions that may impact treatment. TTE assessment of left ventricular systolic function helps to guide the choice of pharmacologic therapy for ventricular rate control in chronic AF. (See
         <a class="medical medical_review" href="/z/d/html/938.html" rel="external">
          "Control of ventricular rate in patients with atrial fibrillation who do not have heart failure: Pharmacologic therapy"
         </a>
         .)
        </p>
        <p>
         TTE can also detect left ventricular hypertrophy, focal wall motion abnormalities suggestive of myocardial infarction, and conditions less frequently associated with AF, including pericarditis (pericardial effusion), pulmonary embolus (dilated and poorly functioning right ventricle), and aortic stenosis (AF is generally poorly tolerated in this disorder and does not occur until very late in the disease). (See
         <a class="medical medical_review" href="/z/d/html/8117.html" rel="external">
          "Medical management of asymptomatic aortic stenosis in adults", section on 'Atrial fibrillation'
         </a>
         .)
        </p>
        <p>
         Left ventricular dysfunction, as determined from the TTE, independently predicts an increased risk of a stroke in patients with AF. Analysis of 1066 patients entered into three prospective clinical trials evaluating the role of anticoagulation in nonvalvular AF (BAATAF, SPINAF, and SPAF) found that, among patients in the placebo or control groups, the incidence of a stroke was 9.3 percent per year in patients with moderate to severe left ventricular dysfunction compared with 4.4 percent per year in those with normal or mildly abnormal left ventricular systolic function (
         <a class="graphic graphic_figure graphicRef70244" href="/z/d/graphic/70244.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid12">
          12
         </a>
         ]. The predictive value of left ventricular dysfunction for thromboembolic risk has been confirmed in many other studies. (See
         <a class="medical medical_review" href="/z/d/html/128998.html" rel="external">
          "Atrial fibrillation in adults: Selection of candidates for anticoagulation", section on 'CHA2DS2-VASc score'
         </a>
         .)
        </p>
        <p>
         While TTE is recommended for all patients presenting with their first episode of AF, repeated TTE is not indicated when the patient has recurrent episodes unless there is a concern that the clinical situation has changed (eg, new heart failure).
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h1">
          TRANSESOPHAGEAL ECHOCARDIOGRAPHY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The preceding observations provide the rationale for the performance of TTE in all patients presenting with their first episode of AF. On the other hand, TEE should be reserved for patients in whom the diagnostic information will lead to alterations in therapy. It is a moderately invasive imaging technique that provides superior visualization of posterior structures, such as the left atrium and left atrial appendage (LAA).
        </p>
        <p>
         TEE has particular value in estimating thromboembolic risk in different clinical settings:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         It can detect LAA and right atrial appendage thrombi (
         <a class="graphic graphic_movie graphicRef56080" href="/z/d/graphic/56080.html" rel="external">
          movie 1
         </a>
         and
         <a class="graphic graphic_movie graphicRef66795" href="/z/d/graphic/66795.html" rel="external">
          movie 2
         </a>
         ) for patients being considered for early cardioversion. In this setting, there is little additional benefit from TTE prior to TEE, as most of the necessary information can be derived from the TEE with its superior assessment of both appendages. (See
         <a class="medical medical_review" href="/z/d/html/906.html" rel="external">
          "Prevention of embolization prior to and after restoration of sinus rhythm in atrial fibrillation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         While data suggest a role of TEE for patients who have not received a full month of therapeutic anticoagulation prior to cardioversion, there does not appear to be a role for routine TEE prior to cardioversion in patients who have been adequately anticoagulated with
         <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">
          warfarin
         </a>
         or direct oral anticoagulant (DOAC) for at least four weeks prior to cardioversion. However, TEE immediately prior to elective cardioversion should be considered for those patients at increased risk for left atrial thrombi (eg, rheumatic mitral valve disease, recent/prior thromboembolism, severe left ventricular systolic dysfunction) or those with a transiently subtherapeutic international normalized ratio (INR) or who have missed doses of DOAC in the month prior to elective cardioversion. (See
         <a class="medical medical_review" href="/z/d/html/906.html" rel="external">
          "Prevention of embolization prior to and after restoration of sinus rhythm in atrial fibrillation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Among patients in paroxysmal or chronic AF, abnormalities in the LAA (thrombus, dense spontaneous echo contrast, or flow velocity ≤20 cm/s) or the presence of a complex aortic plaque increases the risk of a thromboembolic event and are more likely in patients with clinical risk factors for thromboembolism (
         <a class="graphic graphic_figure graphicRef55452" href="/z/d/graphic/55452.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Another role of TEE is for assessment of the adequacy of complete exclusion of the LAA for those undergoing surgical or percutaneous (eg, Watchman device) LAA occlusion. This assessment is helpful in determining the duration of anticoagulation following LAA occlusion. (See
         <a class="medical medical_review" href="/z/d/html/928.html" rel="external">
          "Atrial fibrillation: Left atrial appendage occlusion"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Left atrial thrombi
         </span>
         <span class="headingEndMark">
          —
         </span>
         A main advantage of TEE is that it provides superior visualization of posterior structures, such as the left atrium and LAA as well as the anterior right atrial appendage. This is particularly important for the detection of thrombi, spontaneous echocontrast (a precursor to thrombus), and depressed atrial appendage ejection velocities as these metrics are not assessable with TTE.
        </p>
        <p>
         The ability of TTE to identify or exclude left atrial or atrial appendage thrombi (as well as right atrial appendage thrombi) is quite limited, with a reported sensitivity of 39 to 63 percent, due largely to poor visualization of the LAA [
         <a href="#rid14">
          14,15
         </a>
         ]. By contrast, TEE permits detection of thrombus in both the left atrium (
         <a class="graphic graphic_movie graphicRef51472" href="/z/d/graphic/51472.html" rel="external">
          movie 3
         </a>
         and
         <a class="graphic graphic_movie graphicRef64234" href="/z/d/graphic/64234.html" rel="external">
          movie 4
         </a>
         ) and the LAA (
         <a class="graphic graphic_movie graphicRef56080" href="/z/d/graphic/56080.html" rel="external">
          movie 1
         </a>
         and
         <a class="graphic graphic_movie graphicRef66795" href="/z/d/graphic/66795.html" rel="external">
          movie 2
         </a>
         ).
        </p>
        <p>
         TEE evidence of thrombus in the body of the left atrium is very uncommon. The vast majority of thrombi are seen in the LAA with thrombi seen in approximately 13 percent of patients presenting with nonrheumatic AF of more than three days duration [
         <a href="#rid16">
          16-18
         </a>
         ]. The prevalence is increased in high-risk patients with mitral stenosis (33 percent in one series) [
         <a href="#rid19">
          19
         </a>
         ], left ventricular systolic dysfunction, enlargement of the left atrium or LAA, spontaneous echo contrast, a recent thromboembolic event (43 percent in one report) [
         <a href="#rid20">
          20
         </a>
         ], and CHADS2 score [
         <a href="#rid21">
          21
         </a>
         ]. Recurrent embolization in the last setting may be due to migration of the residual thrombus. On the other hand, the apparent lack of atrial thrombi in 57 percent of these patients probably reflects migration of the entire thrombus during the embolic event, a thrombus not visualized by TEE due to its small size, or another source for the embolus. Thrombus in the right atrial appendage is far less common.
        </p>
        <p>
         The sensitivity and specificity of TEE for left atrial thrombi (in patients in whom the left atrium was directly examined at surgery) are 93 to 100 percent and 99 to 100 percent, respectively [
         <a href="#rid14">
          14,15
         </a>
         ]. In a review of 231 patients in whom only 5.2 percent had a left atrial thrombus, TEE has a positive and negative predictive value of 86 and 100 percent, respectively [
         <a href="#rid14">
          14
         </a>
         ]. For patients who are not candidates for TEE due to esophageal stricture or another contraindication, intracardiac echocardiography with the catheter in the main pulmonary artery has been shown to be at least as efficacious as TEE for identifying atrial appendage thrombi [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
         One potential limitation of these studies is that they were performed by experienced operators and the accuracy may not be replicable at all institutions. Additionally, the complementary role of three-dimension real-time TEE for atrial appendage thrombus is unknown. The use of an endocardial border definition echocontrast agent may help define small thrombi in the atrial appendage [
         <a href="#rid23">
          23
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/906.html" rel="external">
          "Prevention of embolization prior to and after restoration of sinus rhythm in atrial fibrillation"
         </a>
         .)
        </p>
        <p>
         Studies from the Stroke Prevention in Atrial Fibrillation (SPAF) investigators confirmed the usefulness of TEE for predicting thromboembolism [
         <a href="#rid13">
          13,24
         </a>
         ]. This study involved 786 patients with nonrheumatic AF, 382 of whom were at high clinical risk for a thromboembolism (eg, women &gt;75 years of age and patients with systolic blood pressure &gt;160 mmHg or a history of previous thromboembolism, impaired left ventricular function, or recent congestive heart failure). The rate of stroke was increased over threefold when TEE evidence of dense spontaneous echo contrast was present, increased by threefold for reduced (&lt;20 cm/second) LAA peak ejection velocity and for LAA thrombus, and increased by fourfold by complex aortic plaque.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Spontaneous echo contrast
         </span>
         <span class="headingEndMark">
          —
         </span>
         Spontaneous echo contrast (SEC or "smoke") refers to the presence of dynamic, smoke-like echoes seen during TEE in the left atrium or atrial appendage (
         <a class="graphic graphic_movie graphicRef51472" href="/z/d/graphic/51472.html" rel="external">
          movie 3
         </a>
         and
         <a class="graphic graphic_movie graphicRef66795" href="/z/d/graphic/66795.html" rel="external">
          movie 2
         </a>
         ). Although most widely studied in the left atrium, SEC also occurs in the right atrium [
         <a href="#rid16">
          16,25
         </a>
         ]. (See
         <a class="local">
          'Right atrial thrombi'
         </a>
         below.)
        </p>
        <p>
         SEC is thought to reflect increased erythrocyte aggregation caused by low shear rate due to altered atrial flow dynamics and uncoordinated atrial systole [
         <a href="#rid26">
          26,27
         </a>
         ]. Erythrocyte aggregation is mediated by plasma proteins, especially fibrinogen, which promotes red cell rouleaux formation by moderating the normal electrostatic forces (due to negatively charged membranes) which keep erythrocytes from aggregating [
         <a href="#rid28">
          28
         </a>
         ].
        </p>
        <p>
         SEC is a strong risk factor for and may be the preceding stage to thrombus formation and thromboembolic events [
         <a href="#rid13">
          13,24,29,30
         </a>
         ]. The following clinical characteristics of SEC have been identified:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         SEC is present in over 50 percent of all patients with AF and in over 80 percent of those with LAA thrombi or a recent thromboembolic event [
         <a href="#rid12">
          12,13,20,24,25,29,30
         </a>
         ]. Furthermore, serial TEE studies have shown that SEC subsequently develops in many patients with chronic AF (44 percent in one report) who do not have SEC on their initial TEE [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The LAA peak outflow velocity can be estimated by TEE and SEC semiquantitatively graded as marked or dense if present throughout the entire cardiac cycle, or faint when intermittent [
         <a href="#rid24">
          24,29
         </a>
         ]. The risk of thromboembolism increases as these parameters worsen [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         SEC is associated with clinical risk factors for thromboembolism, including a prior thromboembolic event, left ventricular systolic dysfunction, and hypertension (
         <a class="graphic graphic_figure graphicRef55452" href="/z/d/graphic/55452.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid24">
          24,31
         </a>
         ] as well as CHADS2 risk score. On the other hand, it is less common in patients with mitral regurgitation [
         <a href="#rid29">
          29
         </a>
         ] which, as noted above, appears to protect against clinical thromboembolism in chronic AF, presumably by minimized stasis in the left atrium and atrial appendage [
         <a href="#rid8">
          8-11
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">
          Warfarin
         </a>
         , which leads to thrombus resolution and a lower incidence of thromboembolism, does not affect the presence of SEC, since it does not change the underlying hemodynamic abnormality [
         <a href="#rid28">
          28,30,32
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1031.html" rel="external">
          "Atrial fibrillation in adults: Use of oral anticoagulants"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Blood flow velocity
         </span>
         <span class="headingEndMark">
          —
         </span>
         The ability to estimate blood flow velocity in the left or right atrium and left and right atrial appendage permits a more quantifiable measure of stasis. A low LAA blood flow velocity (less than 20 cm/second) is associated with the presence of appendage thrombus [
         <a href="#rid25">
          25,29,33
         </a>
         ] and with denser SEC [
         <a href="#rid24">
          24,29
         </a>
         ]. The risk of stroke increases sharply with marked reductions in blood flow velocity (&lt;15 cm/sec), particularly in the LAA or posterior left atrium [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p>
         It has been suggested that left atrial blood flow velocity also may be a predictor of the likelihood of maintaining sinus rhythm after cardioversion. In one report, a high peak LAA blood flow velocity (&gt;40 cm/sec) identified patients with an increased likelihood of remaining in sinus rhythm one year after cardioversion [
         <a href="#rid35">
          35
         </a>
         ]. In comparison, low blood velocity was of limited predictive value. Other reports have been conflicting on the predictive value of low LAA blood flow velocity for the maintenance of sinus rhythm [
         <a href="#rid36">
          36,37
         </a>
         ].
        </p>
        <p>
         An explanation for ongoing thromboembolism in patients with paroxysmal AF and apparently maintained sinus rhythm may be related to a mechanical discordance between the body of the left atrium and the LAA (ie, an AF LAA pulse wave Doppler phenotype with sinus rhythm electrocardiogram and body of the left atrium motion) [
         <a href="#rid38">
          38
         </a>
         ]. The reproducibility and consistency of this finding are unknown, but retrospective data suggest a discordance in up to 25 percent of patients with paroxysmal AF.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Right atrial thrombi
         </span>
         <span class="headingEndMark">
          —
         </span>
         Few data are available comparing the sensitivity, specificity, and accuracy of TTE and TEE for right atrial and right atrial appendage thrombi, but the right atrial appendage is rarely seen by TTE. By contrast, right atrial or atrial appendage thrombi are also easily seen by TEE (
         <a class="graphic graphic_diagnosticimage graphicRef68756" href="/z/d/graphic/68756.html" rel="external">
          image 1
         </a>
         ). They are much less common than left atrial thrombi in patients in AF, occurring in 3 to 6 percent of cases (versus 15 to 20 percent for left atrial thrombi) [
         <a href="#rid16">
          16,25
         </a>
         ]. The majority of patients with right atrial thrombi also have markedly depressed right ventricular systolic function, rheumatic tricuspid stenosis or prosthetic valve, or left atrial thrombi [
         <a href="#rid12">
          12
         </a>
         ]. Cardioversion should be deferred even if patients have isolated right atrial thrombi.
        </p>
        <p class="headingAnchor" id="H140087294">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/112091.html" rel="external">
          "Society guideline links: Atrial fibrillation"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Routine performance of transthoracic echocardiography is suggested for all patients presenting with their first episode of atrial fibrillation (AF) to obtain information regarding atrial size, ventricular function, valvular function, and possible pericardial effusion. Repeated transthoracic echocardiographic examinations for recurrent presentations of AF are not necessary unless the clinical presentation has changed. If available, data from prior transthoracic echocardiography (TTE) when the patient was in sinus rhythm is useful to determine the patient's relative dependence on sinus rhythm/atrial contribution to total left ventricular filling. (See
         <a class="local">
          'Indications'
         </a>
         above and
         <a class="local">
          'Transthoracic echocardiography'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The main advantage of moderately invasive transesophageal echocardiography (TEE) is its ability to detect left and right atrial appendage thrombi and patients at risk for thrombi because of the presence of spontaneous echo contrast or reduced left atrial appendage (LAA) blood flow velocity as well as aortic plaque. The main clinical use of TEE for AF is in the management of early cardioversion in patients with AF of more than 48 hours or high-risk patients with AF of shorter duration who are candidates for cardioversion. (See
         <a class="local">
          'Indications'
         </a>
         above and
         <a class="local">
          'Transesophageal echocardiography'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/906.html" rel="external">
          "Prevention of embolization prior to and after restoration of sinus rhythm in atrial fibrillation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There does not appear to be a role for routine TEE prior to cardioversion in patients who have been adequately anticoagulated with
         <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">
          warfarin
         </a>
         or direct oral anticoagulant (DOAC) for at least four weeks prior to cardioversion. However, TEE immediately prior to elective cardioversion should be considered for those patients at increased risk for left atrial thrombi (eg, rheumatic mitral valve disease, recent/prior thromboembolism, severe left ventricular systolic dysfunction) or those with a transiently subtherapeutic international normalized ratio (INR) or who have missed doses of DOAC in the month prior to elective cardioversion. (See
         <a class="local">
          'Indications'
         </a>
         above and
         <a class="local">
          'Transesophageal echocardiography'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/906.html" rel="external">
          "Prevention of embolization prior to and after restoration of sinus rhythm in atrial fibrillation", section on 'Transesophageal echocardiography-based approach'
         </a>
         .)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Dittrich HC, Pearce LA, Asinger RW, et al. Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. Am Heart J 1999; 137:494.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sanfilippo AJ, Abascal VM, Sheehan M, et al. Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study. Circulation 1990; 82:792.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manning WJ, Leeman DE, Gotch PJ, Come PC. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol 1989; 13:617.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manning WJ, Silverman DI, Katz SE, et al. Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation. J Am Coll Cardiol 1994; 23:1535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Höglund C, Rosenhamer G. Echocardiographic left atrial dimension as a predictor of maintaining sinus rhythm after conversion of atrial fibrillation. Acta Med Scand 1985; 217:411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dittrich HC, Erickson JS, Schneiderman T, et al. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol 1989; 63:193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brodsky MA, Allen BJ, Capparelli EV, et al. Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation. Am J Cardiol 1989; 63:1065.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blackshear JL, Pearce LA, Asinger RW, et al. Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. Am J Cardiol 1993; 72:840.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ozkan M, Kaymaz C, Kirma C, et al. Predictors of left atrial thrombus and spontaneous echo contrast in rheumatic valve disease before and after mitral valve replacement. Am J Cardiol 1998; 82:1066.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nakagami H, Yamamoto K, Ikeda U, et al. Mitral regurgitation reduces the risk of stroke in patients with nonrheumatic atrial fibrillation. Am Heart J 1998; 136:528.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goldsmith IR, Blann AD, Patel RL, Lip GY. Reduced indexes of left atrial hypercoagulability in patients with severe mitral regurgitation. Am J Cardiol 2000; 86:234.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials. Arch Intern Med 1998; 158:1316.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zabalgoitia M, Halperin JL, Pearce LA, et al. Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators. J Am Coll Cardiol 1998; 31:1622.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manning WJ, Weintraub RM, Waksmonski CA, et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study. Ann Intern Med 1995; 123:817.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hwang JJ, Chen JJ, Lin SC, et al. Diagnostic accuracy of transesophageal echocardiography for detecting left atrial thrombi in patients with rheumatic heart disease having undergone mitral valve operations. Am J Cardiol 1993; 72:677.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manning WJ, Silverman DI, Keighley CS, et al. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study. J Am Coll Cardiol 1995; 25:1354.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weigner MJ, Thomas LR, Patel U, et al. Early cardioversion of atrial fibrillation facilitated by transesophageal echocardiography: short-term safety and impact on maintenance of sinus rhythm at 1 year. Am J Med 2001; 110:694.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klein AL, Grimm RA, Murray RD, et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001; 344:1411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Srimannarayana J, Varma RS, Satheesh S, et al. Prevalence of left atrial thrombus in rheumatic mitral stenosis with atrial fibrillation and its response to anticoagulation: a transesophageal echocardiographic study. Indian Heart J 2003; 55:358.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manning WJ, Silverman DI, Waksmonski CA, et al. Prevalence of residual left atrial thrombi among patients with acute thromboembolism and newly recognized atrial fibrillation. Arch Intern Med 1995; 155:2193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ayirala S, Kumar S, O'Sullivan DM, Silverman DI. Echocardiographic predictors of left atrial appendage thrombus formation. J Am Soc Echocardiogr 2011; 24:499.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anter E, Silverstein J, Tschabrunn CM, et al. Comparison of intracardiac echocardiography and transesophageal echocardiography for imaging of the right and left atrial appendages. Heart Rhythm 2014; 11:1890.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jung PH, Mueller M, Schuhmann C, et al. Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events. Cardiovasc Ultrasound 2013; 11:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Ann Intern Med 1998; 128:639.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Divitiis M, Omran H, Rabahieh R, et al. Right atrial appendage thrombosis in atrial fibrillation: its frequency and its clinical predictors. Am J Cardiol 1999; 84:1023.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Black IW, Chesterman CN, Hopkins AP, et al. Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation. J Am Coll Cardiol 1993; 21:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fatkin D, Herbert E, Feneley MP. Hematologic correlates of spontaneous echo contrast in patients with atrial fibrillation and implications for thromboembolic risk. Am J Cardiol 1994; 73:672.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fatkin D, Loupas T, Low J, Feneley M. Inhibition of red cell aggregation prevents spontaneous echocardiographic contrast formation in human blood. Circulation 1997; 96:889.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fatkin D, Kelly RP, Feneley MP. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 1994; 23:961.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Black IW, Hopkins AP, Lee LC, Walsh WF. Left atrial spontaneous echo contrast: a clinical and echocardiographic analysis. J Am Coll Cardiol 1991; 18:398.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Puwanant S, Varr BC, Shrestha K, et al. Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation. J Am Coll Cardiol 2009; 54:2032.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsai LM, Chen JH, Lin LJ, Teng JK. Natural history of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation. Am J Cardiol 1997; 80:897.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Santiago D, Warshofsky M, Li Mandri G, et al. Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: a transesophageal echocardiographic study. J Am Coll Cardiol 1994; 24:159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shively BK, Gelgand EA, Crawford MH. Regional left atrial stasis during atrial fibrillation and flutter: determinants and relation to stroke. J Am Coll Cardiol 1996; 27:1722.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Antonielli E, Pizzuti A, Pálinkás A, et al. Clinical value of left atrial appendage flow for prediction of long-term sinus rhythm maintenance in patients with nonvalvular atrial fibrillation. J Am Coll Cardiol 2002; 39:1443.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verhorst PM, Kamp O, Welling RC, et al. Transesophageal echocardiographic predictors for maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation. Am J Cardiol 1997; 79:1355.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pérez Y, Duval AM, Carville C, et al. Is left atrial appendage flow a predictor for outcome of cardioversion of nonvalvular atrial fibrillation? A transthroacic and transesophageal echocardiographic study. Am Heart J 1997; 134:745.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Warraich HJ, Gandhavadi M, Manning WJ. Mechanical discordance of the left atrium and appendage: a novel mechanism of stroke in paroxysmal atrial fibrillation. Stroke 2014; 45:1481.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 908 Version 19.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10047632" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2144217" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Atrial enlargement as a consequence of atrial fibrillation. A prospective echocardiographic study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2918167" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8195510" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Impaired left atrial mechanical function after cardioversion: relation to the duration of atrial fibrillation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3160222" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Echocardiographic left atrial dimension as a predictor of maintaining sinus rhythm after conversion of atrial fibrillation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2909999" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2705376" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8213525" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9817483" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Predictors of left atrial thrombus and spontaneous echo contrast in rheumatic valve disease before and after mitral valve replacement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9736148" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Mitral regurgitation reduces the risk of stroke in patients with nonrheumatic atrial fibrillation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10913493" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Reduced indexes of left atrial hypercoagulability in patients with severe mitral regurgitation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9645825" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Echocardiographic predictors of stroke in patients with atrial fibrillation: a prospective study of 1066 patients from 3 clinical trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9626843" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation. Stroke Prevention in Atrial Fibrillation III Investigators.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7486462" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8249844" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Diagnostic accuracy of transesophageal echocardiography for detecting left atrial thrombi in patients with rheumatic heart disease having undergone mitral valve operations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7722133" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11403753" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Early cardioversion of atrial fibrillation facilitated by transesophageal echocardiography: short-term safety and impact on maintenance of sinus rhythm at 1 year.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11346805" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14686666" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Prevalence of left atrial thrombus in rheumatic mitral stenosis with atrial fibrillation and its response to anticoagulation: a transesophageal echocardiographic study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7487241" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Prevalence of residual left atrial thrombi among patients with acute thromboembolism and newly recognized atrial fibrillation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21440414" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Echocardiographic predictors of left atrial appendage thrombus formation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25034183" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Comparison of intracardiac echocardiography and transesophageal echocardiography for imaging of the right and left atrial appendages.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23295101" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Contrast enhanced transesophageal echocardiography in patients with atrial fibrillation referred to electrical cardioversion improves atrial thrombus detection and may reduce associated thromboembolic events.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9537937" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10569657" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Right atrial appendage thrombosis in atrial fibrillation: its frequency and its clinical predictors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8426010" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8166064" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Hematologic correlates of spontaneous echo contrast in patients with atrial fibrillation and implications for thromboembolic risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9264497" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Inhibition of red cell aggregation prevents spontaneous echocardiographic contrast formation in human blood.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8106703" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1856407" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Left atrial spontaneous echo contrast: a clinical and echocardiographic analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19926009" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Role of the CHADS2 score in the evaluation of thromboembolic risk in patients with atrial fibrillation undergoing transesophageal echocardiography before pulmonary vein isolation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9382005" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Natural history of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8006260" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Left atrial appendage function and thrombus formation in atrial fibrillation-flutter: a transesophageal echocardiographic study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8636560" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Regional left atrial stasis during atrial fibrillation and flutter: determinants and relation to stroke.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11985905" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Clinical value of left atrial appendage flow for prediction of long-term sinus rhythm maintenance in patients with nonvalvular atrial fibrillation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9165157" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Transesophageal echocardiographic predictors for maintenance of sinus rhythm after electrical cardioversion of atrial fibrillation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9351743" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Is left atrial appendage flow a predictor for outcome of cardioversion of nonvalvular atrial fibrillation? A transthroacic and transesophageal echocardiographic study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24643411" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Mechanical discordance of the left atrium and appendage: a novel mechanism of stroke in paroxysmal atrial fibrillation.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
